GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Estrella Immunopharma Inc (NAS:ESLA) » Definitions » 12-1 Month Momentum %

ESLA (Estrella Immunopharma) 12-1 Month Momentum % : -32.56% (As of Oct. 31, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Estrella Immunopharma 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-10-31), Estrella Immunopharma's 12-1 Month Momentum % is -32.56%.

The industry rank for Estrella Immunopharma's 12-1 Month Momentum % or its related term are showing as below:

ESLA's 12-1 Month Momentum % is ranked worse than
70.54% of 1446 companies
in the Biotechnology industry
Industry Median: -8.55 vs ESLA: -32.56

Competitive Comparison of Estrella Immunopharma's 12-1 Month Momentum %

For the Biotechnology subindustry, Estrella Immunopharma's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Estrella Immunopharma's 12-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Estrella Immunopharma's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Estrella Immunopharma's 12-1 Month Momentum % falls into.



Estrella Immunopharma  (NAS:ESLA) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Estrella Immunopharma  (NAS:ESLA) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Estrella Immunopharma 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Estrella Immunopharma's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Estrella Immunopharma Business Description

Traded in Other Exchanges
N/A
Address
5858 Horton Street, Suite 170, Emeryville, CA, USA, 94608
Estrella Immunopharma Inc is a preclinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer.

Estrella Immunopharma Headlines